Revised International Staging System (R-ISS) for Multiple Myeloma
ورودیهای بالینی بیمار
حداقل ۱ — حداکثر ۳
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
The Revised International Staging System (R-ISS) for Multiple Myeloma calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include iss stage. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Myeloma staging combining ISS, LDH and high-risk cytogenetics.
Clinical Indication
The Revised International Staging System (R-ISS) for Multiple Myeloma is indicated for bedside clinical practice to support Myeloma staging combining ISS, LDH and high-risk cytogenetics.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.
Limitations & Contraindications
Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.
Clinical Pearls & Action Plan
Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.
R-ISS I: ISS I + normal LDH + standard-risk CA. R-ISS III: ISS III + (high LDH or high-risk CA). R-ISS II: neither
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| iss_stage | integer | Yes | ISS stage (1-3) |
| ldh_high | boolean | Yes | LDH above upper limit of normal |
| high_risk_cytogenetics | boolean | Yes | High-risk cytogenetics [del(17p), t(4;14), t(14;16)] |
Evidence-Based References (EBM)
- Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised International Staging System for multiple myeloma. J Clin Oncol. 2015;33(26):2863-2869.